PTC Therapeutics Provides a Corporate Update and Reports First Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Turkish Stocks Fall 6%, Triggering Market-wide Circuit Breaker - Bloomberg
PTC Therapeutics (PTCT) Misses Q1 EPS by 40c, Beats on Revenue
April 27, 2023 4:07 PM EDTPTC Therapeutics (NASDAQ: PTCT) reported Q1 EPS of ($1.88), $0.40 worse than the analyst estimate of ($1.48). Revenue for the quarter came in at $220.4 million versus the consensus estimate of $205.47 million.
GUIDANCE:
PTC Therapeutics sees FY2023 revenue of $0.94-1 billion vs $0.87 billion... More
